TrialAmerican journal of hematology2026

HOPE Kids 2: Phase 3, Randomized Trial of Voxelotor in Children With SCD and Conditional Cerebral Blood Flow Velocities.

Halima Bello-Manga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.